We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.68B
AUM Growth
-$141M
Cap. Flow
+$92.2M
Cap. Flow %
1.97%
Top 10 Hldgs %
29.84%
Holding
496
New
49
Increased
233
Reduced
148
Closed
29

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$28.9M
2
ORCL icon
Oracle
ORCL
+$24.3M
3
MDT icon
Medtronic
MDT
+$18.6M
4
EBAY icon
eBay
EBAY
+$15.1M
5
FISV
Fiserv Inc
FISV
+$7.95M

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Healthcare 17.18%
3 Financials 10.96%
4 Industrials 10.82%
5 Consumer Staples 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQV icon
26
IQVIA
IQV
$39.3B
$52.1M 1.11%
225,324
-4,127
-2% -$977K
UNP icon
27
Union Pacific
UNP
$174B
$51.5M 1.1%
188,558
+4,066
+2% +$1.03M
PG icon
28
Procter & Gamble
PG
$339B
$49.2M 1.05%
322,313
+5,752
+2% +$900K
MRK icon
29
Merck
MRK
$318B
$46M 0.98%
560,563
-438
-0.1% -$34.5K
NOC icon
30
Northrop Grumman
NOC
$81.2B
$46M 0.98%
102,752
-1,044
-1% -$431K
SYK icon
31
Stryker
SYK
$130B
$45.5M 0.97%
170,361
-689
-0.4% -$178K
CSCO icon
32
Cisco
CSCO
$479B
$42.2M 0.9%
757,064
+18,259
+2% +$1.03M
ABBV icon
33
AbbVie
ABBV
$435B
$41.8M 0.89%
257,953
+7,079
+3% +$1.03M
ZTS icon
34
Zoetis
ZTS
$30B
$41.6M 0.89%
220,693
-7,353
-3% -$1.45M
ABT icon
35
Abbott
ABT
$187B
$41.4M 0.88%
349,969
+7,238
+2% +$897K
MCD icon
36
McDonald's
MCD
$195B
$41.4M 0.88%
167,454
-860
-0.5% -$214K
SYY icon
37
Sysco
SYY
$40.3B
$40.9M 0.87%
500,351
+13,652
+3% +$1.1M
CVX icon
38
Chevron
CVX
$366B
$39M 0.83%
239,423
+2,404
+1% +$345K
BSX icon
39
Boston Scientific
BSX
$71.5B
$37.2M 0.79%
+839,214
New +$36.4M
MDLZ icon
40
Mondelez International
MDLZ
$79.9B
$36.3M 0.78%
578,509
-3,282
-0.6% -$214K
SHW icon
41
Sherwin-Williams
SHW
$89.8B
$35.5M 0.76%
142,174
-336
-0.2% -$92.8K
ENB icon
42
Enbridge
ENB
$112B
$34M 0.73%
737,266
+10,212
+1% +$437K
MKC icon
43
McCormick & Company Non-Voting
MKC
$14.2B
$33.6M 0.72%
337,092
-5,084
-1% -$497K
CCI icon
44
Crown Castle
CCI
$32.2B
$33.2M 0.71%
179,675
+2,968
+2% +$528K
APH icon
45
Amphenol
APH
$209B
$32.4M 0.69%
859,122
-8,154
-0.9% -$316K
ADP icon
46
Automatic Data Processing
ADP
$108B
$30.1M 0.64%
132,190
-271
-0.2% -$58K
CMCSA icon
47
Comcast
CMCSA
$90B
$29.7M 0.64%
635,130
+1,420
+0.2% +$68.4K
SSNC icon
48
SS&C Technologies
SSNC
$18.6B
$29.1M 0.62%
387,537
+55
+0% +$4.3K
LOW icon
49
Lowe's Companies
LOW
$125B
$27.6M 0.59%
136,661
+7,373
+6% +$1.7M
GOOG icon
50
Alphabet (Google) Class C
GOOG
$4.32T
$25.2M 0.54%
180,480
+4,360
+2% +$593K

Similar funds

Bradley Foster & Sargent's Q1 2022 Portfolio in Review

As of Q1 2022, Bradley Foster & Sargent held 496 positions worth $4.68B, down 2.9% from $4.82B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bradley Foster & Sargent's Q1 2022 filing shows 49 new, 233 increased, 148 reduced and 29 closed positions. Its largest new stake was Boston Scientific: 839,214 shares worth $37.2M. The largest sale was T-Mobile US, an estimated $28.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Bradley Foster & Sargent's largest Q1 2022 buy was Boston Scientific: 839,214 shares worth $37.2M.
  • Bradley Foster & Sargent added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $17M increase.
  • Bradley Foster & Sargent's biggest Q1 2022 reduction was T-Mobile US, cutting an estimated $28.9M.
  • Bradley Foster & Sargent fully exited Booz Allen Hamilton in Q1 2022, selling an estimated $2.72M.
  • Bradley Foster & Sargent's ten largest holdings make up 30% of its $4.68B portfolio in Q1 2022.
  • Bradley Foster & Sargent opened 49 new positions and closed 29 in Q1 2022.
  • Bradley Foster & Sargent's portfolio value fell 2.9% quarter-over-quarter to $4.68B.

Based on Bradley Foster & Sargent's 13F filing for Q1 2022, filed 16 May 2022.